NCT06945978View on ClinicalTrials.gov

Validation of a miRNA Panel to Optimize Treatment Response in Patients With Metastatic Pancreatic Cancer (mirPANC 2)

RecruitingOBSERVATIONAL

Enrollment

60

Participants

Timeline

Start Date

January 21, 2025

Primary Completion Date

October 31, 2027

Study Completion Date

December 31, 2027

Conditions

Pancreatic CancerMetastasisEpigenetic

Trial Locations (1)

Unknown

RECRUITING

A Beneficência Portuguesa de São Paulo, São Paulo

All Listed Sponsors

lead

Benedito Mauro Rossi

OTHER